IL6R and AA amyloidosis: These observations lead to the discrepancy that TCZ therapy may have a beneficial effect on periodontitis, amyloid A amyloidosis, and B cell hyperreactivity, while TCZ medication increased serum levels of IL‐6 and sIL‐6R.